Evidence map›Paper›PMID 34439392›Full record

ArticleCancers2021

Adipsin-Dependent Secretion of Hepatocyte Growth Factor Regulates the Adipocyte-Cancer Stem Cell Interaction.

Masahiro Mizuno, Behnoush Khaledian, Masao Maeda, Takanori Hayashi, Seiya Mizuno, Eiji Munetsuna, Takashi Watanabe, Seishi Kono, Seiji Okada, Motoshi Suzuki and 6 more

Abstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. The pleiotropic roles of adipocyte secretome in remodeling breast cancer.Journal of experimental & clinical cancer research : CR · 2022
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Masahiro MizunoDepartment of Biochemistry, Fujita Health University School of Medicine, Toyoake 4701192, Japan.
Behnoush KhaledianDepartment of Biochemistry, Fujita Health University School of Medicine, Toyoake 4701192, Japan.ORCID 0000-0002-1651-5549
Masao MaedaDepartment of Biochemistry, Fujita Health University School of Medicine, Toyoake 4701192, Japan.
Takanori HayashiDepartment of Biochemistry, Fujita Health University School of Medicine, Toyoake 4701192, Japan.
Seiya MizunoLaboratory Animal Resource Center, Transborder Medical Research Center, Faculty of Medicine, University of Tsukuba, Tsukuba 3058575, Japan.
Eiji MunetsunaDepartment of Biochemistry, Fujita Health University School of Medicine, Toyoake 4701192, Japan.
Takashi WatanabeDepartment of Biochemistry, Fujita Health University School of Medicine, Toyoake 4701192, Japan.
Seishi KonoDivision of Breast and Endocrine Surgery, Kobe University Graduate School of Medicine, Kobe 6500017, Japan.
Seiji OkadaDivision of Hematopoiesis, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 8600811, Japan.ORCID 0000-0003-3124-5206
Motoshi SuzukiDepartment of Molecular Oncology, Fujita Health University School of Medicine, Toyoake 4701192, Japan.
Shintaro TakaoDivision of Breast and Endocrine Surgery, Kobe University Graduate School of Medicine, Kobe 6500017, Japan.
Hironobu MinamiDivision of Medical Oncology/Hematology, Kobe University Graduate School of Medicine, Kobe 6500017, Japan.
Naoya AsaiDepartment of Pathology, Fujita Health University School of Medicine, Toyoake 4701192, Japan.
Fumihiro SugiyamaLaboratory Animal Resource Center, Transborder Medical Research Center, Faculty of Medicine, University of Tsukuba, Tsukuba 3058575, Japan.
Satoru TakahashiLaboratory Animal Resource Center, Transborder Medical Research Center, Faculty of Medicine, University of Tsukuba, Tsukuba 3058575, Japan.
Yohei ShimonoDepartment of Biochemistry, Fujita Health University School of Medicine, Toyoake 4701192, Japan.ORCID 0000-0002-6256-4704

Funding

Fujita Health University NAJapan Society for the Promotion of Science 15K14381, 18K07231, 21H02769Japan Society for the Promotion of Science 19K09106Kanazawa University NAPrincess Takamatsu Cancer Research Fund NAPromotion and Mutual Aid Corporation for Private Schools of Japan NA
6 · The paper itself

Abstract

Adipose tissue is a component of the tumor microenvironment and is involved in tumor progression. We have previously shown that adipokine adipsin (CFD) functions as an enhancer of tumor proliferation and cancer stem cell (CSC) properties in breast cancers. We established the Cfd-knockout (KO) mice and the mammary adipose tissue-derived stem cells (mADSCs) from them. Cfd-KO in mADSCs significantly reduced their ability to enhance tumorsphere formation of breast cancer patient-derived xenograft (PDX) cells, which was restored by the addition of Cfd in the culture medium. Hepatocyte growth factor (HGF) was expressed and secreted from mADSCs in a Cfd-dependent manner. HGF rescued the reduced ability of Cfd-KO mADSCs to promote tumorsphere formation in vitro and tumor formation in vivo by breast cancer PDX cells. These results suggest that HGF is a downstream effector of Cfd in mADSCs that enhances the CSC properties in breast cancers.

Indexed as

adipocyteadipsinbreast cancercancer stem cellshepatocyte growth factor

Identifiers

PMID34439392
PMCPMC8393397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.